Quantcast

Latest Pharmaceutical drug Stories

2014-09-15 16:29:14

Patients starting on generic statins vs. branded statins had an eight percent lower rate of cardiovascular events and death WOONSOCKET, R.I., Sept. 15, 2014 /PRNewswire/ -- A new study by researchers at CVS Health (NYSE: CVS) and Brigham and Women's Hospital published today in the Annals of Internal Medicine, is the first to investigate whether starting on a generic versus a brand-name drug for the treatment of high cholesterol is associated with improved health outcomes. The...

2014-09-11 23:02:27

Hurricane season is here, and it’s time to plan ahead for potential disasters. Sugar Land, TX (PRWEB) September 11, 2014 Hurricane season has begun, and history has proven that the end of the season can often be the most dangerous. MedX Pharmacy is here to help their customers plan ahead and be prepared for sudden disaster. Always make sure to keep an adequate supply of medication on hand in case disaster strikes without warning. Don’t wait until your down to your last 2 dosages of...

2014-09-10 08:31:41

Earlier this year upon CFDA approval to the IOPtiMate[TM] system, a strategic distribution agreement was signed with a target of at least 100 systems in China - the world's largest glaucoma markets TEL AVIV, Israel, September 10, 2014 /PRNewswire/ -- BioLight Life Sciences Investments Ltd. (TASE: BOLT, OTCQX:BLGTY), a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, announces the first sale of an IOPtiMate(TM)...

2014-09-09 12:29:19

MENLO PARK, Calif., Sept. 9, 2014 /PRNewswire/ -- SRI International, an independent nonprofit research institute, and Nobelpharma, a Japanese pharmaceutical company, have entered into a licensing agreement to test SR16234, an SRI drug candidate that may be effective in treating endometriosis. SR16234 is a member of a class of drugs known as selective estrogen receptor modulators (SERMs) that regulate the effects of the hormone estrogen. "This important collaboration is addressing a...

2014-09-02 23:08:24

Scale Inhibitor Market report focuses on the basis of product type, technology, and application by region in terms of value, volume also this report aims to estimate the global market for 2014 & to project the expected demand of the same by 2019.(http://www.marketsandmarkets.com/Market-Reports/scale-inhibitors-market-482.html) (PRWEB) September 02, 2014 The new research report “Scale Inhibitor Market by Type (Phosphonates, Carboxylate/Acrylic, Sulfonates and Others), and by...

2014-09-02 23:03:28

REMIND-A-CAP™ will help the 50% of Americans who do not follow their physician's orders when taking prescription medicine while reducing some of the $290 billion spent each year in avoidable medical expenses attributed to non-adherence New York, NY (PRWEB) September 02, 2014 A New York City based company is focused on addressing the non-adherence epidemic with a simple, yet revolutionary, product that will have far-reaching, positive effects including increasing life span and...

2014-09-02 08:28:22

ALBANY, New York, September 2, 2014 /PRNewswire/ -- According to a new market report published "Biological Drugs Market [http://www.marketresearchreports.biz/analysis/177969 ] - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 is expected to grow at a CAGR of 10.1% from 2014 to 2020. Biological drugs are typically derived from living cells and are used in the treatment and prevention of various diseases such as cancer, blood-related...

2014-09-01 23:01:31

The Firm is evaluating potential Lipitor lawsuits on behalf of individuals who allegedly developed Lipitor diabetes injuries after taking the cholesterol-lowering statin drug. New York, NY (PRWEB) September 01, 2014 More than 200 Lipitor lawsuit (http://www.thelipitorlawsuit.com/) filings have been added to a federal litigation that continues to progress in the U.S. District Court, District of South Carolina, Bernstein Liebhard LLP reports. A federal Case List published on August 15th...

2014-08-28 12:29:50

Ribbon-Cutting Ceremony Scheduled for September 3, 2014 ROCKVILLE, Md., Aug. 28, 2014 /PRNewswire/ -- Tasly Pharmaceuticals, Inc., a global leader in Pharmaceuticals, Biologics, and Nutraceuticals, will hold a ribbon-cutting ceremony on September 3, 2014, in Tasly's corporate offices in Rockville, MD. The ceremony will mark the official launch of Tasly Pharmaceuticals, Inc. as the North American headquarters of Tasly Holding Group, a global technology company established in China...

2014-08-26 12:30:12

DALLAS, August 26, 2014 /PRNewswire/ -- According to the new research report "Scale Inhibitor Market by Type (Phosphonates, Carboxylate/Acrylic, Sulfonates and Others), and by Application (Power & Construction, Mining, Oil & Gas, Water & Waste Water Treatment, Food & Beverage and Others) - Global Trends & Forecast to 2019", defines and segments the global scale inhibitor market with an analysis and forecast for types and applications by volume as well...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.